Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 4.7B | 4.6B | 4.2B | 4.1B |
| Cost of revenue | 1.5B | 1.5B | 1.3B | 1.3B |
| Gross profit | 3.2B | 3.1B | 2.9B | 2.9B |
| Operating expense | ||||
| Research & development | 443M | 459M | 407M | 383M |
| Selling general and admin | 1.6B | 1.6B | 1.6B | 1.4B |
| Other operating expenses | 14M | 9M | 5M | 9M |
| Operating income | 937M | 790M | 718M | 799M |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 82M | 80M | 79M | 77M |
| Other income expense | -49M | -230M | 29M | -302M |
| Pretax income | 805M | 585M | 669M | 420M |
| Tax provision | 133M | 23M | 200M | 98M |
| Net income | 672M | 562M | 468M | 322M |
| Basic EPS | 0.5 | 0.4 | 0.3 | 0.2 |
| Diluted EPS | 0.5 | 0.4 | 0.3 | 0.2 |
| Basic average shares | 1.7B | 1.7B | 1.7B | 1.6B |
| Diluted average shares | 1.7B | 1.7B | 1.7B | 1.7B |
| EBITDA | 1.2B | 1.2B | 1.0B | 1.1B |
| Net income from continuing op. | 672M | 562M | 469M | 322M |
| Minority interests | 2M | 4M | 0 | 2M |
| Preferred stock dividends | — | — | — | — |